The REMEDY project aims to advance the delivery of large, hydrophilic molecules into the brain, addressing a significant challenge in treating neurological disorders. The project builds on a newly patented polymeric nanoparticulate system, stabilized reversed micelles (WO2024013245A1), capable of encapsulating proteins, maintaining stability in aqueous environments, and achieving therapeutic concentrations in the brain via systemic administration.